Program to Promote Engagement in Care for the Prevention of Recidivism (PEPS)
Primary Purpose
Suicide, Health Care Seeking Behavior, Case Management
Status
Unknown status
Phase
Not Applicable
Locations
Study Type
Interventional
Intervention
suicide attempt patient using PEPS Program
Sponsored by
About this trial
This is an interventional prevention trial for Suicide
Eligibility Criteria
Inclusion Criteria:
- Age ≥18.
- Male and female.
- Admission to CH St Denis for a suicide attempt.
- Referral for outpatient follow-up.
- Patient with no psychiatric follow-up or who has been out of follow-up for at least three months.
- Patient having given their written informed consent.
Exclusion Criteria:
- Patients not affiliated with social security or state medical aid.
- Patients who do not have the required faculties to be evaluated (cognitive and delusional disorders).
- Patients treated for more than 72 hours after their procedure (maximum length of stay in the UAS and/or in medical intensive care.
- Patient currently under psychiatric care.
- Patients who cannot be called back by telephone (no telephone, homeless, incarceration).
- Patients who do not master the French language.
Sites / Locations
Arms of the Study
Arm 1
Arm 2
Arm Type
Other
Experimental
Arm Label
suicide attempt patient who will receive sanitory supervision
Suicide attempt patient who will participate to PEPS Program
Arm Description
The control group will establish the health monitoring
The intervention group will test the program of Promotion of Commitment to Care for the Prevention of Suicidal Recidivism.
Outcomes
Primary Outcome Measures
Clinical Global Impression (CGI)
rating scales are measures of symptom severity, treatment response and the efficacy of treatments in treatment studies of patients with mental disorders.
Suicide Intent Scale
The Suicide Intent Scale (SIS) developed by A.T. BECK in 1974, is the only scale that focuses solely on the assessment of the suicide attempt that has just taken place.
Montgomery-Asberg depression rating scale
This scale is widely used to measure the changes brought about by the treatment of depression. It assesses the severity of symptoms in a wide variety of areas such as mood, sleep and appetite, physical and mental fatigue, and thoughts of suicide.
Secondary Outcome Measures
Evaluating the effectiveness of the P.E.P.S. program in preventing suicidal recidivism
percentage of all suicidants who relapse during the 12-month study period.
Evaluate the level of possible generalization of the program
percentage of all suicides of subjects likely to benefit from the program (subjects fulfilling the inclusion and non-inclusion criteria).
Evaluate the feasibility of the program
percentage of subjects included in the intervention group who received all interventions); weighted by the percentage of acceptance to participate in the study
Full Information
1. Study Identification
Unique Protocol Identification Number
NCT04366466
Brief Title
Program to Promote Engagement in Care for the Prevention of Recidivism
Acronym
PEPS
Official Title
Program to Promote Commitment to Care for the Prevention of Suicidal Recurrence (Health Monitoring and Case Management) Versus Usual Treatment (Health Monitoring): Randomized Controlled Interventional Study in Routine Care.
Study Type
Interventional
2. Study Status
Record Verification Date
April 2020
Overall Recruitment Status
Unknown status
Study Start Date
May 2020 (Anticipated)
Primary Completion Date
August 2021 (Anticipated)
Study Completion Date
September 2021 (Anticipated)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor-Investigator
Name of the Sponsor
Januel
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
Yes
5. Study Description
Brief Summary
In France, the number of emergency visits for suicide attempts is estimated at 220,000 per year. Suicide management aims to reduce suicide risk factors in order to improve the mental health of patients and prevent recurrences.
To day, no study has compared the approaches to health surveillance and case management in a clinical trial, nor established the benefit of each on commitment to care and beyond the prevention of suicidal recurrence.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Suicide, Health Care Seeking Behavior, Case Management
7. Study Design
Primary Purpose
Prevention
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Model Description
Controlled, randomized and prospective study of a cohort of suicide victims comparing an experimental (interventional) group to a control group (usual treatment)
Masking
None (Open Label)
Allocation
Randomized
Enrollment
138 (Anticipated)
8. Arms, Groups, and Interventions
Arm Title
suicide attempt patient who will receive sanitory supervision
Arm Type
Other
Arm Description
The control group will establish the health monitoring
Arm Title
Suicide attempt patient who will participate to PEPS Program
Arm Type
Experimental
Arm Description
The intervention group will test the program of Promotion of Commitment to Care for the Prevention of Suicidal Recidivism.
Intervention Type
Other
Intervention Name(s)
suicide attempt patient using PEPS Program
Other Intervention Name(s)
Suicide attempt patient using sanitary supervision
Intervention Description
The research protocol consists of two phases separated by randomization.
A Hospital Phase common to both groups:
Day zero is the day of the suicide attempt for which the patient came to the hospital.
A post-hospital phase including the P.E.P.S. program for the intervention group and telephone reminders for the usual treatment group.
Primary Outcome Measure Information:
Title
Clinical Global Impression (CGI)
Description
rating scales are measures of symptom severity, treatment response and the efficacy of treatments in treatment studies of patients with mental disorders.
Time Frame
Day 0
Title
Suicide Intent Scale
Description
The Suicide Intent Scale (SIS) developed by A.T. BECK in 1974, is the only scale that focuses solely on the assessment of the suicide attempt that has just taken place.
Time Frame
Day 0
Title
Montgomery-Asberg depression rating scale
Description
This scale is widely used to measure the changes brought about by the treatment of depression. It assesses the severity of symptoms in a wide variety of areas such as mood, sleep and appetite, physical and mental fatigue, and thoughts of suicide.
Time Frame
Day 0
Secondary Outcome Measure Information:
Title
Evaluating the effectiveness of the P.E.P.S. program in preventing suicidal recidivism
Description
percentage of all suicidants who relapse during the 12-month study period.
Time Frame
1 year
Title
Evaluate the level of possible generalization of the program
Description
percentage of all suicides of subjects likely to benefit from the program (subjects fulfilling the inclusion and non-inclusion criteria).
Time Frame
1 year
Title
Evaluate the feasibility of the program
Description
percentage of subjects included in the intervention group who received all interventions); weighted by the percentage of acceptance to participate in the study
Time Frame
1 year
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Age ≥18.
Male and female.
Admission to CH St Denis for a suicide attempt.
Referral for outpatient follow-up.
Patient with no psychiatric follow-up or who has been out of follow-up for at least three months.
Patient having given their written informed consent.
Exclusion Criteria:
Patients not affiliated with social security or state medical aid.
Patients who do not have the required faculties to be evaluated (cognitive and delusional disorders).
Patients treated for more than 72 hours after their procedure (maximum length of stay in the UAS and/or in medical intensive care.
Patient currently under psychiatric care.
Patients who cannot be called back by telephone (no telephone, homeless, incarceration).
Patients who do not master the French language.
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Youcef BENCHERIF
Phone
01.43.09.32.32
Email
y.bencherif@epsve.fr
First Name & Middle Initial & Last Name or Official Title & Degree
Rusheenthira THAVASEELAN
Phone
0143.0932.32
Email
r.thavaseelan@epsve.fr
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Fayçal MOUAFFAK
Organizational Affiliation
Investigateur Principal
Official's Role
Principal Investigator
12. IPD Sharing Statement
Plan to Share IPD
No
Citations:
PubMed Identifier
33884617
Citation
Witt KG, Hetrick SE, Rajaram G, Hazell P, Taylor Salisbury TL, Townsend E, Hawton K. Psychosocial interventions for self-harm in adults. Cochrane Database Syst Rev. 2021 Apr 22;4(4):CD013668. doi: 10.1002/14651858.CD013668.pub2.
Results Reference
derived
Learn more about this trial
Program to Promote Engagement in Care for the Prevention of Recidivism
We'll reach out to this number within 24 hrs